Mainz Biomed NV experienced recent insider activity involving proposed sales by officer Guido Baechler on May 15 and May 22, 2026. These filings follow a significant purchase by Kevin Michael Donahue recorded in October 2025. No further transactions occurred within the last three months, reflecting a period of limited recent market participation by company leadership.